Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S1PR4 | O95977 | 7/20 | 0.56 |
| ▸ | MAPT | P10636 | 2/20 | 0.55 |
| ▸ | HPGD | P15428 | 4/20 | 0.55 |
| ▸ | RAB9A | P51151 | 3/20 | 0.55 |
| ▸ | TSHR | P16473 | 3/20 | 0.55 |
| ▸ | NPC1 | O15118 | 2/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.51 |
| ▸ | NLRP1 | Q9C000 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.49 |
| ▸ | TP53 | P04637 | 1/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.48 |
| ▸ | MAOA | P21397 | 1/20 | 0.48 |
| ▸ | MAOB | P27338 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL96584 | 0.95 | S1PR4 (0.55) | S1PR4MAPTHPGDRAB9ATSHR | |
| SCHEMBL11090540 | 0.91 | S1PR4 (0.57) | S1PR4MAPTHPGDRAB9ATSHR | |
| SCHEMBL22557984 | 0.83 | KDM4E (0.57) | MAPTHPGDRAB9ATSHRNPC1 | |
| SCHEMBL11413525 | 0.81 | S1PR4 (0.66) | S1PR4MAPTTDP1 | |
| SCHEMBL22558161 | 0.80 | L3MBTL1 (0.45) | S1PR4MAPTHPGDRAB9ATSHR | |
| SCHEMBL3736949 | 0.80 | TDP1 (0.56) | S1PR4MAPTHPGDRAB9ATSHR | |
| SCHEMBL98231 | 0.80 | ALDH1A1 (0.54) | S1PR4MAPTRAB9ATSHRTDP1 | |
| SCHEMBL7237501 | 0.80 | MAPT (0.58) | S1PR4MAPTHPGDRAB9ATSHR | |
| SCHEMBL8410383 | 0.78 | TDP1 (0.58) | S1PR4MAPTHPGDRAB9ATSHR | |
| SCHEMBL9214093 | 0.78 | MAPT (0.57) | S1PR4MAPTHPGDRAB9ATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114206831-A | Conjugates of auxin analogs | 以色列国家农业部、农村发展农业研究组织·沃尔卡尼中心 | 2022-03-18 | — | — | CN | disclosed |
| EP-3956294-A1 | CONJUGATES OF AUXIN ANALOGS | The State of Israel, Ministry of Agriculture and Rural Development, Agricultural Research Organization (ARO) (Volcani Center) (IL) | 2022-02-23 | — | — | EP | disclosed |
| US-20220030866-A1 | CONJUGATES OF AUXIN ANALOGS | THE STATE OF ISRAEL, MINISTRY OF AGRICULTURE & RURAL DEVELOPMENT, AGRICULTURAL RESEARCH ORGANIZATION (IL) | 2022-02-03 | — | — | US | disclosed |
| WO-2020212993-A1 | CONJUGATES OF AUXIN ANALOGS | THE STATE OF ISRAEL, MINISTRY OF AGRICULTURE & RURAL DEVELOPMENT, AGRICULTURAL RESEARCH ORGANIZATION (ARO) (VOLCANI CENTER) (IL) | 2020-10-22 | — | — | WO | disclosed |
| EP-1421071-A2 | SUBSTITUTED PIPERAZINE AND DIAZEPANE DERIVAIVES AS HISTAMINE H3 RECEPTOR MODULATORS | NOVO NORDISK A/S (DK) | 2004-05-26 | — | — | EP | disclosed |
| WO-2003004480-A2 | SUBSTITUTED PIPERAZINE AND DIAZEPANES AS HISTAMINE H3 RECEPTOR AGONISTS | NOVO NORDISK A/S (DK) | 2003-01-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220030866-A1 | CONJUGATES OF AUXIN ANALOGS | CROCC, CCNY, AGXT | S1PR4 3004/4885MAPT 4290/4885HPGD 4089/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.